During the past decade, Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are "Multiple Myeloma" (2 trials), "B-cell Lymphoma" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Newly Diagnosed Multiple Myeloma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Aspirin" (1 trials), "Atezolizumab" (1 trials) and "CC-5013" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".